+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiopulmonary Stress Testing System Market Research Report by Product (Pulse Oximeter, Stress Blood Pressure Monitor, and Stress ECG), Application, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5122375
  • Report
  • April 2022
  • Region: United States
  • 112 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Cardinal Health
  • Care Medical Ltd
  • Cosmed Medical
  • GE Healthcare
  • NIHON KOHDEN CORPORATION
  • Philips Healthcare
The United States Cardiopulmonary Stress Testing System Market size was estimated at USD 947.46 million in 2021, USD 1,063.33 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.72% to reach USD 1,565.42 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cardiopulmonary Stress Testing System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Pulse Oximeter, Stress Blood Pressure Monitor, and Stress ECG.
  • Based on Application, the market was studied across Preoperative Evaluation and Stress Testing In Sport.
  • Based on End User, the market was studied across Clinical Diagnostic Lab, Hospital, and Rehab Center.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiopulmonary Stress Testing System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cardiopulmonary Stress Testing System Market, including Cardiac Science Corporation, Cardinal Health, Care Medical Ltd, Cosmed Medical, GE Healthcare, NIHON KOHDEN CORPORATION, Philips Healthcare, Thermo Fisher Scientific Ltd, TouchPoint, Vyaire Medical Inc., and W.L. Gore & Associates.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Cardiopulmonary Stress Testing System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Cardiopulmonary Stress Testing System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Cardiopulmonary Stress Testing System Market?
4. What is the competitive strategic window for opportunities in the United States Cardiopulmonary Stress Testing System Market?
5. What are the technology trends and regulatory frameworks in the United States Cardiopulmonary Stress Testing System Market?
6. What is the market share of the leading vendors in the United States Cardiopulmonary Stress Testing System Market?
7. What modes and strategic moves are considered suitable for entering the United States Cardiopulmonary Stress Testing System Market?
Frequently Asked Questions about the U.S. Cardiopulmonary Stress Testing System Market

What is the estimated value of the U.S. Cardiopulmonary Stress Testing System Market?

The U.S. Cardiopulmonary Stress Testing System Market was estimated to be valued at $947.5 Million in 2021.

What is the growth rate of the U.S. Cardiopulmonary Stress Testing System Market?

The growth rate of the U.S. Cardiopulmonary Stress Testing System Market is 8.7%, with an estimated value of $1565.4 Million by 2027.

What is the forecasted size of the U.S. Cardiopulmonary Stress Testing System Market?

The U.S. Cardiopulmonary Stress Testing System Market is estimated to be worth $1565.4 Million by 2027.

Who are the key companies in the U.S. Cardiopulmonary Stress Testing System Market?

Key companies in the U.S. Cardiopulmonary Stress Testing System Market include Cardiac Science Corporation, Cardinal Health, Care Medical Ltd, Cosmed Medical, GE Healthcare, NIHON KOHDEN CORPORATION, Philips Healthcare, Thermo Fisher Scientific Ltd and Vyaire Medical Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cardinal Health
  • Care Medical Ltd
  • Cosmed Medical
  • GE Healthcare
  • NIHON KOHDEN CORPORATION
  • Philips Healthcare

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Cardiopulmonary Stress Testing System Market, by Product
6.1. Introduction
6.2. Pulse Oximeter
6.3. Stress Blood Pressure Monitor
6.4. Stress ECG
7. Cardiopulmonary Stress Testing System Market, by Application
7.1. Introduction
7.2. Preoperative Evaluation
7.3. Stress Testing In Sport
8. Cardiopulmonary Stress Testing System Market, by End User
8.1. Introduction
8.2. Clinical Diagnostic Lab
8.3. Hospital
8.4. Rehab Center
9. California Cardiopulmonary Stress Testing System Market10. Florida Cardiopulmonary Stress Testing System Market11. Illinois Cardiopulmonary Stress Testing System Market12. New York Cardiopulmonary Stress Testing System Market13. Ohio Cardiopulmonary Stress Testing System Market14. Pennsylvania Cardiopulmonary Stress Testing System Market15. Texas Cardiopulmonary Stress Testing System Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Cardiac Science Corporation
17.2. Cardinal Health
17.3. Care Medical Ltd
17.4. Cosmed Medical
17.5. GE Healthcare
17.6. NIHON KOHDEN CORPORATION
17.7. Philips Healthcare
17.8. Thermo Fisher Scientific Ltd
17.9. TouchPoint
17.10. Vyaire Medical Inc.
17.11. W.L. Gore & Associates
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: DYNAMICS
FIGURE 2. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PULSE OXIMETER, 2019-2027 (USD MILLION)
FIGURE 6. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PULSE OXIMETER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 7. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS BLOOD PRESSURE MONITOR, 2019-2027 (USD MILLION)
FIGURE 8. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS BLOOD PRESSURE MONITOR, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 9. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS ECG, 2019-2027 (USD MILLION)
FIGURE 10. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS ECG, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 11. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 12. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY APPLICATION, 2027
FIGURE 14. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PREOPERATIVE EVALUATION, 2019-2027 (USD MILLION)
FIGURE 15. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PREOPERATIVE EVALUATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS TESTING IN SPORT, 2019-2027 (USD MILLION)
FIGURE 17. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS TESTING IN SPORT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 19. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY END USER, 2027
FIGURE 21. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTIC LAB, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTIC LAB, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY HOSPITAL, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY HOSPITAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY REHAB CENTER, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY REHAB CENTER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: FPNV POSITIONING MATRIX
FIGURE 28. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 29. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PULSE OXIMETER, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS BLOOD PRESSURE MONITOR, BY STATE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS ECG, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY PREOPERATIVE EVALUATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY STRESS TESTING IN SPORT, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY CLINICAL DIAGNOSTIC LAB, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET SIZE, BY REHAB CENTER, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: SCORES
TABLE 15. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: BUSINESS STRATEGY
TABLE 16. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: PRODUCT SATISFACTION
TABLE 17. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: RANKING
TABLE 18. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 19. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: MERGER & ACQUISITION
TABLE 20. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 21. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 22. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: INVESTMENT & FUNDING
TABLE 23. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 24. UNITED STATES CARDIOPULMONARY STRESS TESTING SYSTEM MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Cardiac Science Corporation
  • Cardinal Health
  • Care Medical Ltd
  • Cosmed Medical
  • GE Healthcare
  • NIHON KOHDEN CORPORATION
  • Philips Healthcare
  • Thermo Fisher Scientific Ltd
  • TouchPoint
  • Vyaire Medical Inc.
  • W.L. Gore & Associates
Note: Product cover images may vary from those shown

Loading
LOADING...